EBM — Eastwood Bio-Medical Canada Balance Sheet
0.000.00%
- CA$30.31m
- CA$30.38m
- CA$0.70m
Annual balance sheet for Eastwood Bio-Medical Canada, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.123 | 0.021 | 0.04 | 0.018 | 0 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.01 | 0.006 | 0.015 | 0.083 | 0.043 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.173 | 0.058 | 0.101 | 0.151 | 0.044 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.65 | 0.55 | 0.446 | 0.338 | 0.231 |
Other Long Term Assets | |||||
Total Assets | 0.933 | 0.691 | 0.585 | 0.489 | 0.274 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.451 | 0.804 | 0.844 | 1.33 | 1.57 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.474 | 0.835 | 0.879 | 1.33 | 1.57 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.459 | -0.144 | -0.294 | -0.841 | -1.3 |
Total Liabilities & Shareholders' Equity | 0.933 | 0.691 | 0.585 | 0.489 | 0.274 |
Total Common Shares Outstanding |